obesity treatment

obesity treatment

featured image of Forge Biologics Teams Up for Revolutionary Diabetes Therapy!

Forge Biologics Teams Up for Revolutionary Diabetes Therapy!

BIOT

🌟 Forge Biologics partners with Fractyl Health to enhance gene therapy for obesity and diabetes using scalable manufacturing solutions! 🧬🏭🔬📈

featured image of €50 Million Boost for GLP-1 Production in France!

€50 Million Boost for GLP-1 Production in France!

BIOT

🌟 Axplora invests €50M in France! 🏗️ Boosting GLP-1 manufacturing for diabetes and obesity therapies. 💊 Next-gen production by 2026! 🚀

featured image of CordenPharma's €900m Investment to Dominate Peptide Market

CordenPharma’s €900m Investment to Dominate Peptide Market

BIOT

📢 CordenPharma invests €900m in peptide platform expansion, aiming to become a market leader and reach €1bn in sales by 2028. 🔬💊💪

featured image of Breakthrough Obesity Drug: 70 Achieve Over 15 Weight Loss

Breakthrough Obesity Drug: 70 Achieve Over 15 Weight Loss

BIOT

🌍 Roche's obesity drug CT-388 shows impressive results in clinical trial, offering hope for weight loss worldwide! 💊💪 ObesitySolution

featured image of Roche's Breakthrough Obesity Drug: 188 Weight Loss!

Roche’s Breakthrough Obesity Drug: 188 Weight Loss!

BIOT

🔍 Roche's CT-388 shows promising results in treating obesity, with a median weight loss of 18.8 in Phase I trial. 📈💊🩺

featured image of Scientists Discover Fat-Burning Breakthrough to Fight Obesity

Scientists Discover Fat-Burning Breakthrough to Fight Obesity

BIOT

📢 Researchers switch on brown fat cells, revolutionizing obesity research 🔥. Blocking enzyme AC3-AT helps combat obesity in mice. 💡👩‍🔬 Further research needed.

featured image of Spanish Company Acquires ALS Treatment for €1225m

Spanish Company Acquires ALS Treatment for €1225m

BIOT

🇪🇸 Spanish Ferrer Internacional, SA pays €122.5m for ALS candidate, VRG50635, with promising Phase I trial results. 💰🧪

featured image of Revolutionary Partnership Targets $80bn Obesity Treatment Market

Revolutionary Partnership Targets $80bn Obesity Treatment Market

BIOT

🗞️ British companies Arecor Therapeutics and TRx Biosciences partner to develop an oral GLP-1 receptor agonist for obesity treatment. 🍔🍟💊💰💡

featured image of Breakthrough Treatment Prevents Blindness - BlueRock Leads the Way!

Breakthrough Treatment Prevents Blindness – BlueRock Leads the Way!

BIOT

💼 Biotechnology company BlueRock aims to prevent blindness by commercializing a groundbreaking ocular disease treatment. 👀🌟

featured image of Revolutionary RSV Treatment Approved in China!

Revolutionary RSV Treatment Approved in China!

BIOT

📝 AZ's Beyfortus authorized as first RSV treatment in China! 💊🇨🇳 Significant breakthrough in biotech industry. 👏😃

12 Next